<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: We examined whether mivazerol, an alpha2-<z:chebi fb="4" ids="48705">agonist</z:chebi>, had neuroprotective effects after transient forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in rats </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Male Sprague-Dawley rats, anesthetized with <z:chebi fb="2" ids="5615">halothane</z:chebi>, were assigned to one of four groups (n=10 each): control (C, <z:mpath ids='MPATH_458'>normal</z:mpath> saline) and mivazerol 10 microg/kg (M10), 20 microg/kg (M20) and 40 microg/kg (M40) groups </plain></SENT>
<SENT sid="2" pm="."><plain>Thirty minutes after drug administration, forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> was induced with hemorrhagic <z:hpo ids='HP_0002615'>hypotension</z:hpo> and bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> for 10 min, and then the brain was reperfused </plain></SENT>
<SENT sid="3" pm="."><plain>The neurologic outcome was evaluated 24 h, 48 h and 7 days after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, followed by histologic evaluation </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The survival rate during 7 days was significantly lower in group M40 than in groups M10 and M20 (P&lt;0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>The neurologic outcome was significantly better in groups M10 and M20 than in group M40 7 days after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (P&lt;0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>The number of intact neurons in hippocampal CA1 was significantly greater in group M20 than in the other groups (P&lt;0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>Neuronal injury in the neocortex was significantly less in group M20 than in groups C and M40 (P&lt;0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Our results suggest that mivazerol, up to 20 microg/kg, provides neuroprotective effects, whereas 40 microg/kg may exaggerate neuronal injury after transient forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in rats </plain></SENT>
</text></document>